SeeBITDAOklahoma

Grifols Biomat USA

Blood and Organ Banks
Estimated valueLow confidence
$983K
$271Klikely range$1.5M
About 3× its yearly profit, typical for a company this size in its industry.
Revenue
$1.5M
a year
Profit (EBITDA)
$328K
22% of revenue
Employees
—
not reported
Leadership
Owner not found yet
We haven't found the owner in public records

How we got $983K

Based on typical figures for its industry (2022 Economic Census), not its own records.

A typical blood and organ banks business in Oklahoma$1.5M
Revenue$1.5M
× 22% profit margin$328K
× 3 sale multiple = value$983K

· Own this business? Correct these figures

What we know

No PPP loan
No 401(k) filing
No reported financials
Company website
Owner not found

What they do

Grifols Biomat USA's Lawton, OK center collects plasma from donors, who are compensated for their donations, to help create therapies for patients with diseases such as immune deficiencies, hemophilia, genetic emphysema, hepatitis, tetanus and rabies.

Products & services
Plasma donationNew donor compensationRefer A Friend BonusAnti-RSV ProgramWalk-Ins

From the company's website. Industry: Blood and Organ Banks.

Compared with similar businesses nearby

BusinessEst. revenueEst. profitDistance
Grifols Biomat USA
this business
$1.5M$328K—
CSL Plasma
Lawton
$10.7M$1.7M1.1 mi
Kirk's EMS
Lawton
$1.5M$328K2.3 mi
KIRK'S EMERGENCY MEDICAL SERVICE INC
Lawton · 61 employees
$9.8M$1.7M2.4 mi
THE HEALTHCARE MANAGEMENT GROUP OF LAWTON INC
Lawton · 73 employees
$13.4M$1.9M2.6 mi
Our Blood Institute
Lawton
$6.1M$1.1M3.1 mi
KIRK'S EMERGENCY SERVICES INC.
Lawton
$8.6M$1.4M9.6 mi

The full calculation

Figures are shown toward the upper part of their range rather than at its middle.

Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.

Estimated value = EBITDA × typical sale multiple$983K
Multiple for this size and industry3×
Value range$271K – $1.5M

This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Blood and Organ Banks businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (22%). Treat these as a rough guide.

Revenue range$525K – $2.0M
EBITDA range$113K – $420K
Industry (NAICS)Blood and Organ Banks (621991)

EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.

Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology

History & advisors

Founded 1909
“Since our founding in 1909, we have worked to advance plasma science.”

From the company's own website and public filings (DOL Form 5500, IRS Form 990, SBA). Roles are as stated there and may be out of date.

Public records

Matched to this business by name and address from public government data; a match can occasionally be wrong.

About Grifols Biomat USA

Grifols Biomat USA is a blood and organ banks company in Lawton, Oklahoma, in business since 1909. Its estimated annual revenue is about $1.5M, with roughly $328K of EBITDA. Its estimated business value is $983K (likely range $271K–$1.5M).

Common questions

Who owns Grifols Biomat USA?
The owner of Grifols Biomat USA isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
How much revenue does Grifols Biomat USA make?
SeeBITDA estimates Grifols Biomat USA's annual revenue at about $1.5M (likely between $525K and $2.0M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
What is Grifols Biomat USA worth?
About $983K, roughly 3× its estimated EBITDA of $328K, typical for a blood and organ banks company its size. Likely range: $271K–$1.5M.
When was Grifols Biomat USA founded?
Grifols Biomat USA has been in business since 1909.